Company intelligence / Profile preview

Sannuo Biological Sensing

Changsha, Hunan, China

Ownership: Private
Development stage: Other

Overview

Sannuo Biological Sensing develops and commercializes point-of-care blood glucose monitors—including both self-monitoring and continuous glucose monitor (CGM) systems—with published evidence of clinical accuracy, including CE certification and ISO 13485 compliance, and ongoing clinical trials in China and Europe for CGM systems[2][5].

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Bionime (strategic cooperation, cross-ownership, China distribution partnership)[9]

Beyond the preview

Go deeper on Sannuo Biological Sensing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sannuo Biological Sensing.

Explore the full profile